Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-871-9 | CAS number: 75-45-6
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Additional information
According to Annex XI No. 2 the testing for oral repeated dose toxicity is technically not possible (not feasible): testing for a specific endpoint may be omitted if it is technically not possible to conduct the study as a consequence of the properties of the substance, e.g. high volatibility. The method described by Annex B.26 - Subchronic oral toxicity - is not applicable.
According to Annex XI No. 2 the testing for dermal repeated dose toxicity
is technically not possible (not feasible): testing for a specific endpoint may be omitted if it is technically not possible to conduct the study as a consequence of the properties of the substance, e.g. high volatibility. The method described by Annex B.28 - Subchronic dermal toxicity - is not applicable.
In a test on inhalative repeated dose toxicity eighty male and eighty female Alderley Park Swiss mice per group were exposed to concentrations of 0, (two groups) 1000, 10,000 or 50,000 ppm (0, 3500, 35,000, 175,000 mg/m3) chlorodifluoromethane, 5 hr/d, 5 d/wk for up to 83 weeks (females) and 94 weeks (males). The only consistent finding was hyperactivity in male mice exposed to 50,000 ppm chlorodifluoromethane. No effects were noted on mortality, body weight gain, haematology and biochemistry nor in histopathology. The No Observed Adverse Effect Concentration (NOAEC) for chlorodifluoromethane in this study was 10,000 ppm (35,000 mg/m3).
Justification for classification or non-classification
The testing of chlorodifluoromethane on oral repeated dose toxicity
is technically not feasable, so this endpoint for this classification can not be determined.The testing of chlorodifluoromethane on dermal repeated dose toxicity
is technically not feasable, so this endpoint for this classification can not be determined.The testing of chlorodifluoromethane on inhalative repeated dose toxicity with Alderley Park Swiss mice gave as
only consistent findings hyperactivity in male mice exposed to 50,000 ppm chlorodifluoromethane. No effects were noted on mortality, body weight gain, haematology and biochemistry nor in histopathology. So a NOAEC for chlorodifluoromethane in this study was derived as 10,000 ppm (35,000 mg/m3) which gives no reason for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
